In AML, ErbB receptors ErbB-1 and ErbB-3 were the main mediators of miR-125a, and the phosphorylation of the downstream effectors AKT and MAPK played key roles in driving proliferation and survival of the AML blasts. Here, EGFR is linked to acute myeloid leukemia.